Article | December 7, 2020

GxP Risk Assessment For Computerized Systems

Source: Egnyte

By Bobby Bouthillette

Risk Decision

There are numerous computer systems used in the life sciences industry. In GxP environments, however, validating and documenting mission-critical systems are required to ensure the integrity of data and audit-readiness. Yet, given the number of systems used, it is unclear which electronic systems require validation and which do not. In our view, a rational, data-driven assessment of a given system helps companies focus their limited resources on validating the right software for GxP environments.

The checklist below provides a framework for evaluating which software should/not be validated. We have taken a numerical approach to help individuals use data in quantifying risk and final decisions.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online